HGH for Bodybuilding: Use and Precautions

Mechanism: GH then IGF-1

Somatropin is a 191-amino-acid protein, identical to human GH, produced by genetic engineering. Injected subQ, it has a short half-life (3 to 4 h) but triggers a cascade leading to hepatic IGF-1 (Insulin-like Growth Factor 1) production — which is the main mediator of anabolic effects ^[2]. Serum IGF-1 is the follow-up marker on HGH, not GH itself (whose level fluctuates too fast to interpret).

HGH does not suppress the HPTA (testosterone, LH, FSH are not affected). It does inhibit endogenous GH production during use, by negative feedback — but that production restarts fairly quickly after you stop (weeks to months depending on duration of use). No PCT is required.

IU dosing: the ranges

HGH is dosed in international units (IU), not milligrams — a pharmaceutical convention tied to biological activity. The rough conversion is 1 mg ≈ 3 IU (depends on manufacturer).

Doses above 6 IU/day significantly expose users to metabolic side effects (insulin resistance, water retention, carpal tunnel syndrome) and structural ones (organ hypertrophy, growth of extremities over very long term). They are for advanced users and require tight monitoring.

Injection timing and frequency

• SubQ injection (abdomen, thigh), never intramuscular.
• Fasted morning: most common protocol — mimics a physiological GH pulse before the natural morning peak.
• Fasted bedtime: alternative, but can interfere with the nocturnal endogenous GH peak.
• Post-workout: used in 2×/day split, leverages tissue sensitization.
• Far from carbs: a carb-rich meal right before or after an injection blunts the GH response.

Slow effects: 3 to 6 months for structural benefits

This is the main feature to internalize before any investment. HGH effects build over time — not in a short cycle.

• Weeks 1 to 4. Sleep often deeper, mild water retention (feeling 'puffy'), perhaps initial fatigue or brain fog. No visible gain.
• Weeks 4 to 12. Perceptible lipolysis (notably visceral and arm fat), improved recovery, skin looks better hydrated. No marked mass gain yet.
• Months 3 to 6. Progressive lean mass, muscle quality (density), felt joint strength. Targeted effects actually install.
• Beyond 6 months. Benefit plateau or slow continuation depending on dose and environment (training, nutrition, eventual stack).

Users who stop at 8 or 12 weeks concluding that 'HGH does not work' simply stopped before the useful effect window. The financial cost of a 6-month HGH protocol is to anticipate before starting.

Side effects: insulin, water, joints

The HGH side-effect profile is very different from a steroid's — it is metabolic before being hormonal.

Insulin resistance

It is the most important side effect to monitor. GH raises fasting glucose and reduces insulin sensitivity — through direct physiological mechanism, not as 'toxicity' ^[3]. A fasting glucose and HbA1c (glycated hemoglobin) are mandatory before, at 3 months, then every 3 to 6 months. Diabetic or prediabetic users should avoid HGH without strict medical supervision.

Water retention and carpal tunnel syndrome

GH causes dose-dependent sodium and water retention. At moderate doses (2 to 4 IU), it stays discreet; at higher doses, it becomes marked (puffy face, swollen fingers). Carpal tunnel syndrome (tingling, numbness in the fingers) is linked to this retention and hits a meaningful share of high-dose users. It regresses on stopping or lowering the dose.

Joint pain (initial paradox)

Counter-intuitive: HGH improves joint health mid-term (cartilage and tendon quality) but often causes joint pain in the first weeks, linked to retention and tissue remodeling. They generally resolve in 4 to 8 weeks.

Internal tissue hypertrophy

At high doses (beyond 6 IU/day sustained over several months), HGH can hypertrophy internal organs (heart, intestine, kidneys) — the mechanism behind the 'HGH gut' observed in some high-level competitors ^[5]. This risk is dose-dependent and tied to extended use at 'pharmacological' doses — barely present at moderate anti-aging or recomp doses.

Cost: a structuring factor

Unlike a testosterone cycle that runs into tens of dollars per month, authentic pharmaceutical HGH runs into hundreds or even thousands of dollars per month depending on dose. A modest dose of 2 IU/day of branded pharmaceutical product represents several hundred dollars monthly; a 6 IU/day dose multiplies accordingly. Underground lab (UGL) versions are cheaper but quality is highly variable — see below.

This factor changes everything: a 6-month HGH protocol at recomp dose (4 to 6 IU/day) represents an investment of several thousand dollars — to anticipate before starting, and to factor into the decision whether or not to frame the experiment. The opportunity cost relative to an alternative protocol (GH secretagogues, short steroid stack) is often unfavorable for users who do not have a specific objective that justifies HGH.

Source quality: the most counterfeited market

HGH is probably the most counterfeited product on the underground market. Independent analyses routinely document: major underdosing (products at 30 or 50% of advertised activity), complete substitution (cheap peptides or inactive solutions), purity issues (immunogenic impurities that generate anti-GH antibodies and cancel biological effect over time).

• Branded pharmaceutical (Pfizer Genotropin, Lilly Humatrope, Novo Nordisk Norditropin, Merck Saizen). Guaranteed quality, maximum cost. Procurement nearly impossible without prescription in most countries.
• Generic pharmaceutical (Hygetropin, real Jintropin, etc.). Historically good quality for real Chinese pharmaceutical production, but the market is saturated with counterfeits using these brands. Authenticity verification essential (manufacturer verification codes, batch number, trusted source).
• Underground (UGL). Highly variable quality. Without a verifiable certificate of analysis and an IGF-1 panel before/after, real efficacy remains unknown.

Monitoring: what to watch

• IGF-1. Reference efficacy marker. Baseline then 4 to 6 weeks, then every 3 months. Often-cited target: high end of the age-normal range.
• Fasting glucose and HbA1c. Baseline then every 3 months. If HbA1c crosses 5.7% (prediabetes), reassess the protocol.
• T3/T4 and TSH. GH can reveal or worsen subclinical hypothyroidism. Watch, particularly at high doses.
• General panel. CBC, renal and hepatic function, lipids — as with any other protocol. See the blood work on cycle guide.

HGH follow-up is more metabolic than hormonal. The cost of regular bloods is marginal next to the product itself — there is no reason to skip them.

Frequently asked questions